1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Sakuramoto S, Sasako M, Yamaguchi T,
Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi
Y, Imamura H, et al: Adjuvant chemotherapy for gastric cancer with
S-1, an oral fluoropyrimidine. N Engl J Med. 357:1810–1820. 2007.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Sano T, Sasako M, Yamamoto S, Nashimoto A,
Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y
and Okajima K: Gastric cancer surgery: Morbidity and mortality
results from a prospective randomized controlled trial comparing D2
and extended para-aortic lymphadenectomy-Japan Clinical Oncology
Group study 9501. J Clin Oncol. 22:2767–2773. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sasako M, Sakuramoto S, Katai H, Kinoshita
T, Furukawa H, Yamaguchi T, Nashimoto A, Fujii M, Nakajima T and
Ohashi Y: Five-year outcomes of a randomized phase III trial
comparing adjuvant chemotherapy with S-1 versus surgery alone in
stage II or III gastric cancer. J Clin Oncol. 29:4387–4393. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Kodama M, Kitadai Y, Sumida T, Ohnishi M,
Ohara E, Tanaka M, Shinagawa K, Tanaka S, Yasui W and Chayama K:
Expression of platelet-derived growth factor (PDGF)-B and
PDGF-receptor β is associated with lymphatic metastasis in human
gastric carcinoma. Cancer Sci. 101:1984–1989. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sumida T, Kitadai Y, Shinagawa K, Tanaka
M, Kodama M, Ohnishi M, Ohara E, Tanaka S, Yasui W and Chayama K:
Anti-stromal therapy with imatinib inhibits growth and metastasis
of gastric carcinoma in an orthotopic nude mouse model. Int J
Cancer. 128:2050–2062. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Tsuda T, Yoshida K, Tsujino T, Nakayama H,
Kajiyama G and Tahara E: Coexpression of platelet-derived growth
factor (PDGF) A-chain and PDGF receptor genes in human gastric
carcinomas. Jpn J Cancer Res. 80:813–817. 1989. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ostman A: PDGF receptors-mediators of
autocrine tumor growth and regulators of tumor vasculature and
stroma. Cytokine Growth Factor Rev. 15:275–286. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Risau W, Drexler H, Mironov V, Smits A,
Siegbahn A, Funa K and Heldin CH: Platelet-derived growth factor is
angiogenic in vivo. Growth Factors. 7:261–266. 1992. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bergers G, Song S, MeyerMorse N, Bergsland
E and Hanahan D: Benefits of targeting both pericytes and
endothelial cells in the tumor vasculature with kinase inhibitors.
J Clin Invest. 111:1287–1295. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Pietras K: Increasing tumor uptake of
anticancer drugs with imatinib. Semin Oncol. 31(2): Suppl 6.
S18–S23. 2004. View Article : Google Scholar
|
12
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union Against Cancer (UICC) TNM Classification of
Malignant Tumors. 7th. Wiley-Blackwell; Oxford: pp. 73–77. 2009
|
13
|
Erben P, Horisberger K, Muessle B, Müller
MC, Treschl A, Ernst T, Kähler G, Ströbel P, Wenz F, Kienle P, et
al: mRNA expression of platelet-derived growth factor receptor-beta
and C-KIT: Correlation with pathologic response to cetuximab-based
chemoradiotherapy in patients with rectal cancer. Int J Radiat
Oncol Biol Phys. 72:1544–1550. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Antoniades HN, Galanopoulos T,
NevilleGolden J and O'Hara CJ: Malignant epithelial cells in
primary human lung carcinomas coexpress in vivo platelet-derived
growth factor (PDGF) and PDGF receptor mRNAs and their protein
products. Proc Natl Acad Sci USA. 89:3942–3946. 1992. View Article : Google Scholar : PubMed/NCBI
|
15
|
Vrekoussis T, Stathopoulos EN, Kafousi M,
Navrozoglou I and Zoras O: Expression of endothelial PDGF receptors
alpha and beta in breast cancer: Up-regulation of endothelial PDGF
receptor beta. Oncol Rep. 17:1115–1119. 2007.PubMed/NCBI
|
16
|
Guo Y, Yin J, Zha L and Wang Z:
Clinicopathological significance of platelet-derived growth factor
B, platelet-derived growth factor receptor-β, and E-cadherin
expression in gastric carcinoma. Contemp Oncol (Pozn). 17:150–155.
2013.PubMed/NCBI
|
17
|
Suzuki S, Dobashi Y, Hatakeyama Y, Tajiri
R, Fujimura T, Heldin CH and Ooi A: Clinicopathological
significance of platelet-derived growth factor (PDGF)-B and
vascular endothelial growth factor-A expression, PDGF receptor-β
phosphorylation, and microvessel density in gastric cancer. BMC
cancer. 10:6592010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Paulsson J, Sjöblom T, Micke P, Pontén F,
Landberg G, Heldin CH, Bergh J, Brennan DJ, Jirström K and Ostman
A: Prognostic significance of stromal platelet-derived growth
factor beta-receptor expression in human breast cancer. Am J
Pathol. 175:334–341. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hägglöf C, Hammarsten P, Josefsson A,
Stattin P, Paulsson J, Bergh A and Ostman A: Stromal PDGFRbeta
expression in prostate tumors and non-malignant prostate tissue
predicts prostate cancer survival. PloS One. 5:e107472010.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Sato S, Sato Y, Hatakeyama K, Marutsuka K,
Yamashita A, Takeshima H and Asada Y: Quantitative analysis of
vessels with smooth muscle layer in astrocytic tumors: correlation
with histological grade and prognostic significance. Histol
Histopathol. 26:497–504. 2011.PubMed/NCBI
|
21
|
Chen L, Shi Y, Jiang CY, Wei LX, Lv YL,
Wang YL and Dai GH: Coexpression of PDGFR-alpha, PDGFR-beta and
VEGF as a prognostic factor in patients with hepatocellular
carcinoma. Int J Biol Markers. 26:108–116. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Shinohara ET, Gonzalez A, Massion PP,
Olson SJ, Albert JM, Shyr Y, Carbone DP, Johnson DH, Hallahan DE
and Lu B: PDGFR-beta expression in small cell lung cancer patients.
Int J Radiat Oncol Biol Phys. 67:431–437. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Tailor TD, Hanna G, Yarmolenko PS, Dreher
MR, Betof AS, Nixon AB, Spasojevic I and Dewhirst MW: Effect of
pazopanib on tumor microenvironment and liposome delivery. Mol
Cancer Ther. 9:1798–1808. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kim R, Emi M, Arihiro K, Tanabe K, Uchida
Y and Toge T: Chemosensitization by STI571 targeting the
platelet-derived growth factor/platelet-derived growth factor
receptor-signaling pathway in the tumor progression and
angiogenesis of gastric carcinoma. Cancer. 103:1800–1809. 2005.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Yeo SG and Kim JS, Cho MJ, Kim KH and Kim
JS: Interstitial fluid pressure as a prognostic factor in cervical
cancer following radiation therapy. Clin Cancer Res. 15:6201–6207.
2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Milosevic M, Fyles A, Hedley D, Pintilie
M, Levin W, Manchul L and Hill R: Interstitial fluid pressure
predicts survival in patients with cervix cancer independent of
clinical prognostic factors and tumor oxygen measurements. Cancer
Res. 61:6400–6405. 2001.PubMed/NCBI
|
27
|
Pietras K, Ostman A, Sjöquist M,
Buchdunger E, Reed RK, Heldin CH and Rubin K: Inhibition of
platelet-derived growth factor receptors reduces interstitial
hypertension and increases transcapillary transport in tumors.
Cancer Res. 61:2929–2934. 2001.PubMed/NCBI
|
28
|
Pietras K, Rubin K, Sjöblom T, Buchdunger
E, Sjöquist M, Heldin CH and Ostman A: Inhibition of PDGF receptor
signaling in tumor stroma enhances antitumor effect of
chemotherapy. Cancer Res. 62:5476–5484. 2002.PubMed/NCBI
|
29
|
Emerich DF, Dean RL, Snodgrass P,
Lafreniere D, Agostino M, Wiens T, Xiong H, Hasler B, Marsh J, Pink
M, et al: Bradykinin modulation of tumor vasculature: II.
activation of nitric oxide and phospholipase A2/prostaglandin
signaling pathways synergistically modifies vascular physiology and
morphology to enhance delivery of chemotherapeutic agents to
tumors. J Pharmacol Exp Ther. 296:632–641. 2001.PubMed/NCBI
|
30
|
Wiig H, Tveit E, Hultborn R, Reed RK and
Weiss L: Interstitial fluid pressure in DMBA-induced rat mammary
tumours. Scand J Clin Lab Invest. 42:159–164. 1982. View Article : Google Scholar : PubMed/NCBI
|